Rincon Announces Research Collaboration With Biogen Idec

Rincon Pharmaceuticals announced a collaborative research project with Biogen Idec to evaluate Rincon's eukaryotic algae production platform for therapeutic non-glycosylated proteins. Rincon has demonstrated the utility of algae as a system for the expression and assembly of complex mammalian proteins, including monoclonal antibodies.

()a href="http://biz.yahoo.com/prnews/050519/lath106.html?.v=9" target="_blank">Yahoo News